Long-Acting HIV Treatment Benefits Adults with Barriers to Daily Pill Taking and Adolescents with Suppressed HIV

March 6, 2024 -- Long-acting, injectable antiretroviral therapy (ART) suppressed HIV replication better than oral ART in people who had previously experienced challenges taking daily oral regimens and was found safe in adolescents with HIV viral...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials